Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v4-EN
Language French English
Date Updated 2023-01-03 2020-01-27
Drug Identification Number 02326485 02326485
Brand name MINT-PIOGLITAZONE MINT-PIOGLITAZONE
Common or Proper name Pioglitazone Pioglitazone
Company Name MINT PHARMACEUTICALS INC MINT PHARMACEUTICALS INC
Ingredients PIOGLITAZONE PIOGLITAZONE
Strength(s) 30MG 30MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 count bottles 100 count bottles
ATC code A10BG A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-09 2019-10-09
Estimated end date 2021-12-31 2020-03-31
Actual end date 2022-03-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments